GYKI-16084
GYKI-16084 is a new compound that can be isolated from dog and rat urine. GYKI-16084 can be used in the research of benign prostatic hyperplasia[1].
Product Specifications
CAS Number
[185739-21-3]
UNSPSC
12352005
Target
Endogenous Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/gyki-16084.html
Smiles
O=C1C=CC=NN1CCCNC[C@H]2OC3=CC=CC=C3OC2
Molecular Formula
C16H19N3O3
Molecular Weight
301.34
References & Citations
[1]K. Migléczi, et al. Two Stage Solid Phase Extraction with Subsequent HPLC Isolation for Structure Elucidation of Major Metabolites of (+) - (R) -2-{3- (benzo[1,4]dioxan-2-yl-methylamino) -1-propyl}-3 (2H) -pyridazinone (GYKI-16084) . Chromatographia. 2004, 60, S67–S74.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![DUS2L, CT (DUS2L, DUS2, tRNA-dihydrouridine (20) synthase [NAD (P) +]-like, Up-regulated in lung cancer protein 8, tRNA-dihydrouridine synthase 2-like) (MaxLight 550) discontinued](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
034848-ML550 100 µL
DUS2L, CT (DUS2L, DUS2, tRNA-dihydrouridine (20) synthase [NAD (P) +]-like, Up-regulated in lung cancer protein 8, tRNA-dihydrouridine synthase 2-like) (MaxLight 550) discontinued
Ask
View Details